In several cancers, including lung, colon, breast, pancreas, and prostate, overexpression of EZH2 plays two key roles: (a) modulation of innate and adaptive immune pathways and (b) regulation of stem cell self-renewal, differentiation, and lineage fate (19–21). This evidence concerns the gene EZH2 and cancer.